Mir-10a overexpression is associated with npm1 mutations and mdm4 downregulation in intermediate-risk acute myeloid leukemia

Dmitriy Ovcharenko, Friedrich Stölzel, David Poitz, Fernando A Fierro, Markus Schaich, Andreas Neubauer, Kevin Kelnar, Timothy Davison, Carsten Müller-Tidow, Christian Thiede, Martin Bornhäuser, Gerhard Ehninger, David Brown, Thomas Illmer

Research output: Contribution to journalArticle

29 Scopus citations

Abstract

Objective: The study investigated differential microRNA (miRNA) expression patterns in acute myeloid leukemia (AML) patients with intermediate-risk (IR) characteristics. After characterization and validation of miR-10a, which was specifically upregulated in nucleophosmin 1 (NPM1) mutant AML samples, functional consequences of miR-10a overexpression were further delineated in vitro. Materials and Methods: Microarray analysis of miRNAs in bone marrow samples from AML (IR) patients with NPM1 mutations and healthy donors was performed to detect differential expression patterns. After validation of miRNA expression specific for NPM1 mutation in AML patients by quantitative reverse transcription polymerase chain reaction, a functional target gene search was conducted using complementary DNA microarray data from samples transfected with miR-10a. Potential target gene validation was done using transient transfection of K562 cells followed by Western blotting and luciferase reporter assay. Results: In comparison with wild-type samples, NPM1 mutant AML samples were shown to markedly overexpress miR-10a. Subsequent in vitro miR-10a overexpression induced differential gene expression as determined by microarray analysis. Here the murine double minute 4 (MDM4) gene turned out as a candidate gene for miR-10a. Validation of MDM4 in leukemic cells revealed a robust negative relationship between miR-10a overexpression and MDM4 downregulation. Furthermore, we determined an inverse association between miR-10a and MDM4 expression in AML (IR) samples with respect to their NPM1 mutational status. Conclusions: miR-10a expression is highly characteristic for AML (IR) patients with NPM1 mutations and may influence its biological properties in AML by interfering with the p53 machinery partly regulated by MDM4.

Original languageEnglish (US)
JournalExperimental Hematology
Volume39
Issue number10
DOIs
StatePublished - Oct 2011
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Molecular Biology
  • Hematology

Fingerprint Dive into the research topics of 'Mir-10a overexpression is associated with npm1 mutations and mdm4 downregulation in intermediate-risk acute myeloid leukemia'. Together they form a unique fingerprint.

  • Cite this

    Ovcharenko, D., Stölzel, F., Poitz, D., Fierro, F. A., Schaich, M., Neubauer, A., Kelnar, K., Davison, T., Müller-Tidow, C., Thiede, C., Bornhäuser, M., Ehninger, G., Brown, D., & Illmer, T. (2011). Mir-10a overexpression is associated with npm1 mutations and mdm4 downregulation in intermediate-risk acute myeloid leukemia. Experimental Hematology, 39(10). https://doi.org/10.1016/j.exphem.2011.07.008